
Health Check: These biotechs are awaiting key announcements on St Patrick’s Day
Opthea shares enter trading halt on St Patrick’s Day ahead of a “material” trial update Imricor is on the hunt for funds, reportedly up to $80 million Race Oncology is in pole position for phase I trial start In the diabolically difficult drug development …